Zeclinics y el pez cebra como modelo de negocio

from Biotecnología Capital · host Capital Radio

Simone Calzolari, CEO, y Javier Terriente, director científico de Zeclinics, nos cuentan cómo va esta empresa que ofrece ensayos preclínicos y test de eficacia de nuevos compuestos utilizando el pez cebra como modelo experimental.

Episode metadata supplied by the publisher feed · Published Feb 7, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Zeclinics y el pez cebra como modelo de negocio

0:00 30:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Biotecnología Capital?

This episode is 30 minutes long.

When was this Biotecnología Capital episode published?

This episode was published on February 7, 2022.

Can I download this Biotecnología Capital episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!